Do Novavax and Pfizer/BioNTech’s COVID-19 vaccines get us nearer to freedom?

The federal government has invested in two extra initiatives in search of a coronavirus vaccine, to safe one other 50 million doses. Final week it introduced offers with Novavax and Pfizer/BioNTech, along with agreements already in place for the College of Oxford and College of Queensland vaccines.

Pfizer/BioNTech’s coronavirus vaccine trials have been welcomed by consultants, prompting renewed requires Australia to spend money on new kinds of vaccine manufacturing expertise.

This week an interim evaluation of the vaccine’s part three research was introduced. The businesses discovered it was greater than 90 per cent efficient in defending individuals.

On this episode, senior journalist Jacqueline Maley is joined by healthcare reporter Emma Koehn to debate Australia’s funding in coronavirus vaccines and mRNA expertise.

Our supporters energy our newsrooms and are crucial for the sustainability of stories protection.

Turning into a subscriber additionally will get you unique behind-the-scenes content material and invites to particular occasions. Click on on the hyperlinks to subscribe to The Sydney Morning Herald or The Age.

Signal as much as our Coronavirus Replace publication

Get our Coronavirus Replace publication for the day’s essential developments at a look, the numbers you might want to know and what our readers are saying. Signal as much as The Sydney Morning Herald’s publication here and The Age’s here.